NZ334582A - Polyprotein construct of a papillomavirus - Google Patents
Polyprotein construct of a papillomavirusInfo
- Publication number
- NZ334582A NZ334582A NZ334582A NZ33458296A NZ334582A NZ 334582 A NZ334582 A NZ 334582A NZ 334582 A NZ334582 A NZ 334582A NZ 33458296 A NZ33458296 A NZ 33458296A NZ 334582 A NZ334582 A NZ 334582A
- Authority
- NZ
- New Zealand
- Prior art keywords
- papillomavirus
- sequence
- fragment
- polyprotein construct
- immunogenic variant
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Use of a polyprotein construct comprising at least two amino acid sequences fused directly or indirectly together, where each sequence being the sequence of an early ORF protein of papillomavirus (PV) or an immunogenic variant or fragment thereof, and at least one of the sequences being other than E6 or E7 protein sequence or an immunogenic variant of fragment thereof for the preparation of a composition for eliciting an immune response against papillomavirus in a host animal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPN4439A AUPN443995A0 (en) | 1995-07-27 | 1995-07-27 | Papillomavirus polyprotein |
NZ313108A NZ313108A (en) | 1995-07-27 | 1996-07-26 | Papillomavirus polyprotein constructs |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ334582A true NZ334582A (en) | 2000-07-28 |
Family
ID=25644998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ334582A NZ334582A (en) | 1995-07-27 | 1996-07-26 | Polyprotein construct of a papillomavirus |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ334582A (en) |
-
1996
- 1996-07-26 NZ NZ334582A patent/NZ334582A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1847549A3 (en) | Papillomavirus polyprotein constructs | |
RS51157B (en) | Baff receptor (bcma), an immunoregulatory agent | |
AU6117696A (en) | Nucleic acid respiratory syncytial virus vaccines | |
WO2002005146A3 (en) | Method for disigning protein libraries with altered immunogenicity | |
WO2001034801A3 (en) | Recombinant gelatin in vaccines | |
IL134392A0 (en) | Vaccine against hpv | |
GB2303854B (en) | Helicobacter proteins and vaccines | |
DK0757717T3 (en) | papillomavirus vaccines | |
BR9906927A (en) | Neisseria meningitidis proteins | |
WO1993001210A3 (en) | Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv) | |
AU2002317604A1 (en) | Immunologically significant herpes simplex virus antigens and methods for using same | |
CA2042236A1 (en) | Seroreactive epitopes on proteins of human papillomavirus (hpv) 18 | |
MX9603182A (en) | Hepatitis b vaccine. | |
AU2002309259A1 (en) | Improved polysaccharide and glycoconjugate vaccines_____________ | |
GB0118532D0 (en) | Materials and methods relating to improved vaccination strategies | |
DE69836520D1 (en) | Clostridium perfringens vaccine | |
NZ515041A (en) | Nucleic acid immunization | |
EP0957936A4 (en) | Formulations of recombinant papillomavirus vaccines | |
TW200509964A (en) | VP1 of foot-and-mouth disease virus | |
HU9200583D0 (en) | Method for producing el peptides of rubeola | |
NZ334582A (en) | Polyprotein construct of a papillomavirus | |
AU8405798A (en) | A swine hepatitis e virus and uses thereof | |
AU8156594A (en) | Non-A non-B sequences | |
WO2002060390A3 (en) | Induction of immune responses to isoaspartyl-modified antigens | |
ES2012815A6 (en) | Vaccine against melanoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
EXPY | Patent expired |